Musculoskeletal/Orthopedics

NEJM study assess BMD retesting

A study in the Jan. 19 issue of The New England Journal of Medicine (NEJM) found that in older, postmenopausal women with normal bone…

FDA approves first drug for myelofibrosis

The U.S. Food and Drug Administration has approved Jakafi (ruxolitinb), the first drug approved to treat patients with the bone marrow disease myelofibrosis. Read…

NEJM study assess BMD retesting

A study in the Jan. 19 issue of The New England Journal of Medicine (NEJM) found that in older, postmenopausal women with…
cheryl meeGet your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.

NurseLine Newsletter

  • Hidden

*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.

Test Your Knowledge

Which of the following patients is at the highest risk for developing autonomic dysreflexia (AD)?